A detailed history of Wells Fargo & Company transactions in Electromed, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 552 shares of ELMD stock, worth $8,296. This represents 0.0% of its overall portfolio holdings.

Number of Shares
552
Previous 552 -0.0%
Holding current value
$8,296
Previous $6,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$9.58 - $10.99 $14,264 - $16,364
-1,489 Reduced 72.95%
552 $6,000
Q3 2023

Nov 13, 2023

BUY
$9.24 - $11.43 $18 - $22
2 Added 0.1%
2,041 $21,000
Q2 2023

Aug 15, 2023

BUY
$10.15 - $12.45 $20 - $24
2 Added 0.1%
2,039 $21,000
Q1 2023

May 12, 2023

BUY
$10.03 - $13.6 $10 - $13
1 Added 0.05%
2,037 $21,000
Q4 2022

Feb 13, 2023

BUY
$9.62 - $10.58 $9 - $10
1 Added 0.05%
2,036 $21,000
Q3 2022

Nov 14, 2022

SELL
$8.75 - $11.74 $1,163 - $1,561
-133 Reduced 6.13%
2,035 $20,000
Q2 2022

Aug 12, 2022

BUY
$9.58 - $12.85 $28 - $38
3 Added 0.14%
2,168 $20,000
Q4 2021

Feb 14, 2022

SELL
$10.71 - $13.0 $10,710 - $13,000
-1,000 Reduced 31.6%
2,165 $28,000
Q3 2021

Nov 15, 2021

SELL
$10.82 - $13.66 $21 - $27
-2 Reduced 0.06%
3,165 $34,000
Q2 2021

Aug 16, 2021

SELL
$9.09 - $11.72 $1.24 Million - $1.59 Million
-135,985 Reduced 97.72%
3,167 $35,000
Q1 2021

May 13, 2021

BUY
$9.8 - $12.14 $886,037 - $1.1 Million
90,412 Added 185.5%
139,152 $1.47 Million
Q4 2020

Feb 09, 2021

BUY
$8.16 - $10.28 $125,272 - $157,818
15,352 Added 45.98%
48,740 $479,000
Q3 2020

Nov 05, 2020

BUY
$9.9 - $18.48 $178,744 - $333,656
18,055 Added 117.75%
33,388 $347,000
Q2 2020

Aug 13, 2020

BUY
$10.27 - $17.28 $113,966 - $191,756
11,097 Added 261.97%
15,333 $236,000
Q1 2020

May 14, 2020

BUY
$7.0 - $12.93 $29,652 - $54,771
4,236 New
4,236 $48,000

Others Institutions Holding ELMD

About Electromed, Inc.


  • Ticker ELMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,492,200
  • Market Cap $128M
  • Description
  • Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consist...
More about ELMD
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.